Our results indicate that CYP46A1 promotes α-Syn pathology and nigrostriatal dopaminergic degeneration, whereas depletion of CYP46A1 attenuates damage in a mouse model of synucleinopathy. The gene discussed is CYP46A1; the disease is synucleinopathy.